Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 476-500 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
condition of patients with Covid-19 including saturation of arterial oxygen.
Design:
Phase 3 clinical trial (...) . Immediately after CT-Scan and Covid-19 clinical diagnosis, patients were divided into intervention and control (...) icluded clinical signs of fever (above 38.3 C), dyspnea and cough, and Covid-19 diagnosis based on RT-PCR
performed on 40 patients with Covid-19 in two groups. One group is treated with hydroxychloroquine. The (...) and exclusion criteria:
Inclusion criteria:
Positive result of PCR or CT scan for COVID-19 disease in (...) violet flower, Melilotus officinalis and Bindii) on improving respiratory symptoms in patients with Covid
Study aim:
Determining the effect of guided mental imagery on anxiety, muscle pain and vital signs in patients with Covid-19
Design:
The selected samples will be divided into two groups of (...) criteria:
Should be positive for covid-19 with PCR test;
Satisfaction to participate in the study;
Age
Study aim:
Effectiveness' determination of psychological interventions on the mental health of women referred to hospital and health centres affiliated to the Kerman University of Medical Science in pregnancy, delivery and the postpartum period in the Coronavirus epidemic in 2020
Design:
Empirical intervention-based educational research, With pre-test and post-test, control and intervention groups and simple randomization with a sample size of 60 people
Settings and conduct:
The present study is an empirically-based educational intervention with a pretest-posttest and intervention and control group design which will be done by ethic code achieved by Kerman University of Medical Sciences. Women satisfied to participate in the study will be randomly divided into intervention and control groups. The intervention group will attend 6 psychological counselling group sessions through virtual networks such as WhatsApp or Skype for 90 to 120 minutes. The post-test will be offered to the two groups after the sessions.
Participants/Inclusion and exclusion criteria:
Inclusion criteria: satisfaction to participate in the study, being in a time period of 28 weeks of pregnancy to 28th of postpartum day for women referring for postpartum services, not receiving psychiatric medication, not attending in counselling sessions at the same time of study period
Intervention groups:
Intervention group: Psychological counselling sessions consists of 6 weekly virtual sessions through virtual networks such as WhatsApp or Skype For 90 to 120 minutes. Control group: There is no intervention.
Main outcome variables:
Anxiety, depression, health anxiety
this treatment at home after a visit to the clinics designated by the Department of Health for COVID-19
Participants/Inclusion and exclusion criteria:
Patients with COVID-19 with mild to moderate severity according (...) treatment of COVID-19 according to the protocol of the Ministry of Health along with receiving dairy product
hospitalized patients with COVID-19
Design:
A randomized controlled, double blind clinical trial with a (...) two blinded trial that will be conducted on COVID-19 patients who referred to Ali Asghar Hospital of (...) older with COVID-19 who had hospitalized; Having a definite disease; Having a signed informed consent
Lopinavir/Ritonavir and Interferon beta in patients with COVID-19
Design:
A phase 3 clinical trial with (...) population is 60 patients with COVID-19 (30 patients in control group and 30 in study group).
Participants (...) ) test for COVID-19, primary clinical symptoms, hospitalized, and signing informed consent.
Exclusion
Study aim:
Determining the effect of mandala staining on the anxiety of patients with COVID-19(...) group included patients with Covid19 who underwent Mandala staining for 6 consecutive days and 30 minutes each day. The control group included patients with Covid19 who received only routine care
inflammatory biomarkers in patients with COVID-19
Design:
Clinical trial with control group, with parallel (...) performed on 88 patients with Covid-19 referring to the clinic of Razi Hospital in Ahvaz. Patients are (...) .
Participants/Inclusion and exclusion criteria:
Patients aged 18 to 65 years Laboratory confirmation of Covid-19
patients with mild and moderate acute respiratory distress syndrome caused by COVID-19
Design:
This is a (...) moderate acute respiratory distress syndrome caused by COVID-19 referring to the Besat Hospital in Hamadan (...) to COVID-19,
Bilateral pulmonary infiltration in chest X-ray or CT-scan,
Respiratory distress with
COVID-19
Design:
This is a double-blind randomized clinical trial, phase II, in which 81 eligible (...) eligible patients with moderate to severe acute respiratory distress syndrome caused by COVID-19 referring (...) acute respiratory distress syndrome due to COVID-19,
Bilateral pulmonary infiltration in chest X-ray or
enzymes and clinical symptoms in patients with Covid-19.
Design:
Randomized clinical trial with parallel (...) .
Settings and conduct:
The current trial was performed on diabetic patients with Covid-19 in Amir-Alam (...) patients diagnosed with covid-19 according to the decision of the relevant physician- Not consuming any
patients with or suspected of covid-19 into clinical trial
Design:
- The testing process is two-headed (...) patients
Intervention groups:
Patients with acute respiratory infection (covid-19 suspected or suspected
Study aim:
We aimed to assess the effect of high dose vitamin C on clinical improvement and inflammatory indices in moderate to severe COVID-19 patients.
Design:
Randomized double blind clinical trial (...) .
Participants/Inclusion and exclusion criteria:
Confirmed moderate to severe COVID-19, age more than 18 years
COVID-19 (Before intubation phase) who have not responded to the standard three-drug protocol (...) admitted to Imam Reza hospital in Mashhad who diagnosed with COVID-19 and have not responded to the (...) within 18 to 25 years old; definitive diagnosis with COVID-19; having one of the factors of decrease in
patients with Covid-19 in a clinical trial
Design:
At the beginning of the study, patients will be (...) , Diagnosis of Covid-19 over the past 24 hours, No underlying disease
Exclusion: Hospitalized patients (...) :
clinical symptoms including fever, cough, shortness of breath in COVID-19 patients; need for
mortality in patients with COVID-19
Design:
A randomized, double-blind, placebo-controlled clinical trial (...) definitive or clinical diagnosis of COVID-19
4. Satisfaction with the study collaboration
5.BMI: 18.5-30
6. COVID-19 treatment protocol is almost identical in both groups
7- Patients not participating in other
COVID-19 patients, hospitalization in Firoozgar hospital are randomly divided into two groups of (...) greater than 18 years; Signing a consent form; Diagnosis of COVID-19 by chest CT-scan or RT-PCR test
clinical trial. The study population includes all patients with COVID-19 referring to Abadan hospitals. All (...) severe symptoms of COVID-19 who were admitted to the infectious ward of Ayatollah Taleghani Hospital in (...)COVID-19 with severe symptoms and positive RT-PCR assay of nasopharyngeal samples
Exclusion criteria
Study aim:
Evaluating efficacy and safety of sofosbuvir/ledipasvir in treatment of COVID-19
Design (...) sofosbuvir/ledipasvir in treatment of COVID-19. Fifty eligible patients will be assigned to intervention or (...) old persons with highly suspected or confirmed COVID-19
Exclusion criteria: History of drug allergy
Study aim:
Reducing the incidence of the COVID-19 disease and reducing the hospitalization by (...) patients with COVID-19 who were admitted to medical centers affiliated with Iran University of Medical (...) of 40 who have been in contact with a person with COVID-19 disease
Exclusion Criteria:
Pregnancy
respiratory distress syndrome in patients with COVID-19 (a pilot study)
Design:
Clinical trials have two (...) blind.
Participants/Inclusion and exclusion criteria:
Inclusion criteria: COVID-19 patient; acute respiratory infectious and distress symptoms; Inclusion criterion: COVID-19 patient with mild respiratory
in patients with corona virus (COVID-19) in Rasht in 2020.
Design:
Clinical trial with control group (...) and conduct:
Patients diagnosed with Covid19 are randomly divided into two groups receiving aspirin (...) CT scan or PCR diagnosis of COVID19
Exclusion criteria: patients admitted to the ICU, Patients with
and additional progressive muscle relaxation techniques in patients with long-COVID19 symptoms.
Design:
We included 61 post-COVID-19 patients who came for pulmonary rehabilitation. The pulmonary (...) infection with COVID-19, age over 18 years, primary symptom of dyspnea and fatigability lasting for over one
patients with Covid19 double-blind randomized clinical trial
Design:
This study is a randomized double (...) and exclusion criteria:
We will invite 40 patients with COVID-19 based on inclusion and non-inclusion criteria. Inclusion criteria: 1. Being 20 to 60 years old 2. Diagnosis of COVID-19 based on PCR test 3